Back to SO Squarepoint Ops LLC
VRAX2 quarters
Position history for SOSquarepoint Ops LLC's holdings in VIRAX BIOLABS GROUP LTD
No. Squarepoint Ops exited its VRAX (Virax Biolabs Group) position in Q4 2024. Its Q3 2024 13F listed 40,620 shares worth $78,803. Squarepoint Ops first reported VRAX in Q3 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$78,803
Total Shares Change
-40,620
Quarter-by-Quarter History
Other major holders of VRAX: RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, HRT FINANCIAL LP, Virtu Financial LLC